Objective-To assess the investigation and treatment of cardiac failure in 1995 and to compare this with management in 1992. Design-Retrospective consecutive case study. Setting-University teaching hospital. Subjects-All patients (n = 265) discharged from Aberdeen Royal Infirmary in the first quarter (January of 1995 with a diagnosis of congestive cardiac failure, left ventricular failure, or heart failure (unspecified). These correspond to the International Classification of Diseases 9th revision codings of 428.0, 428.1, and 428.9 respectively. Methods-Sociodemographic and clinical data were extracted from the case notes of the above subjects and compared with similar data from the final six months of 1992. Main outcome measures-The use of echocardiography in confirming the diagnosis and delineating the aetiology of heart failure and the use of angiotensinconverting enzyme (ACE) inhibitors in the treatment of patients diagnosed as having heart failure and without contraindications to these agents. Results-The number of patients discharged in 1995 with a diagnosis including cardiac failure had increased by 55-7% since 1992. The use of echocardiography had also risen from 36-6% to 72% (P < 0 0001) with an associated increase in the proportion of patients discharged on treatment with an ACE inhibitor (40% in 1992 v 55-1% in 1995: P < 0.001). The doses of ACE inhibitors used had also increased significantly (P < 0.001). Most patients with cardiac failure continue to be treated by general physicians, who are less likely to use echocardiography (P < 0.01) or prescribe an ACE inhibitor (P < 0.05) than cardiologists.
of 1995 with a diagnosis of congestive cardiac failure, left ventricular failure, or heart failure (unspecified). These correspond to the International Classification of Diseases 9th revision codings of 428.0, 428.1, and 428.9 respectively. Methods-Sociodemographic and clinical data were extracted from the case notes of the above subjects and compared with similar data from the final six months of 1992. Main outcome measures-The use of echocardiography in confirming the diagnosis and delineating the aetiology of heart failure and the use of angiotensinconverting enzyme (ACE) inhibitors in the treatment of patients diagnosed as having heart failure and without contraindications to these agents. Results-The number of patients discharged in 1995 with a diagnosis including cardiac failure had increased by 55-7% since 1992. The use of echocardiography had also risen from 36-6% to 72% (P < 0 0001) with The prevalence of heart failure is between 0 5-1% and levels are rising.1 2 This results in considerable morbidity and mortality, plus a rapidly increasing economic cost.3 Despite this, cardiac failure remains inadequately investigated and under treated. 6 We assessed the management of patients with cardiac failure in Aberdeen Royal Infirmary in late 1992, and found relatively poor investigation and treatment of the condition.6 Since then the management of heart failure has received considerable publicity with wider dissemination of the results of major studies, both in cardiac and non-specialist journals. In addition, we have reported our results at local meetings with colleagues from other medical specialties. In order to assess whether management has improved in the recent past we have re-examined the investigation and treatment of heart failure in the first quarter of 1995 using the same methods as our previous study, thus completing the audit cycle.
Methods
All patients discharged from the Aberdeen Royal Infirmary during the first three months of 1995 (1 January-31 March) with a diagnosis of congestive cardiac failure, left ventricular failure, or heart failure (unspecified) were identified (n = 265). These correspond to the International Classification of Diseases 9th revision codings of 428.0, 428.1, and 428.9 respectively. Those patients ascribed such a diagnosis were included whether or not heart failure was the primary medical problem during their hospital admission. The first hospital admission during which cardiac failure was diagnosed was regarded as the index admission. The units on which patients had been treated were subdivided in a hierarchical fashion. Those managed at any time on a specialist cardiology ward had this recorded as the principal unit on which treatment occurred. A similar strategy was employed for the remaining patients who were under the care of general medical units, leaving a final subgroup who were entirely treated on non-medical wards. The main outcome measures were (a) the use of echocardiography in confirming the diagnosis and delineating the aetiology of heart failure and (b) the use of ACE inhibitors in the treatment of patients diagnosed as having heart failure and without contraindications to these agents. The accuracy of diagnoses was not assessed because the principal aims were to analyse the investigation of cardiac function Hillis, Al-Mohammad, Wood, Jennings and the treatment of heart failure once diagnosed. In addition, it was felt inappropriate to suggest that diagnoses were erroneous on the basis of retrospective case note data. The echocardiographic findings of patients discharged in 1995 were, however, recorded.
Sociodemographic and clinical details were extracted from the case notes of all subjects discharged in 1995 (table) and compared with similar data from the final six months of 1992 (see reference 6 for full details of this cohort). In our original study two patients were excluded as their case notes could not be located and 13 because they were included in the 4th International Study of Infarct Survival. In 1995 all case notes were retrieved and no patients were excluded. Data from the two time points were compared using Fisher's exact and chi-squared tests with Yates' correction and double sided P values used throughout.
Results
In 1995 an average of 88-3 patients per month were discharged from Aberdeen Royal Infirmary with a diagnosis which included cardiac failure. This represents a 55-7% increase on the equivalent figure for the last six months of 1992: 56-7 patients per month (including those omitted from subsequent analyses: see above). Most had significant heart failure placing them in New York Heart Asssociation grades III or IV and requiring treatment with loop diuretics (table). In 1992 only 36-6% of subjects were investigated by echocardiography. By 1995 this had risen to 72% (P < 0 0001). Of these patients 31 had entirely normal left ventricular function, nine of whom were discharged on an angiotensin-converting enzyme (ACE) inhibitor (none being hypertensive). Forty percent (130/325) of patients with a diagnosis of cardiac failure were discharged on an ACE inhibitor in 1992: in 1995 this had risen to 55-1% (146/265; P < 0 001). Twenty six patients who were not so treated had contraindications to ACE inhibition or other recognised reasons whereby this might not be appropriate: these included aortic stenosis (n = 8), significant mitral stenosis (n = 2), combined mitral and aortic stenosis (n = 1), renal artery stenosis (n = 4), previous adverse reaction (n = 5: severe hypotension = 3, rash = 
